EUCTR2010-018435-18-GB进行中（未招募）不适用
Assessing Platelet Inhibitory Response to Clopidogrel – Feasibility, Safety and Cost Analysis of a Tailored Platelet Inhibition Strategy for Elective PCI Patients - Plavix and Prasugrel
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Able to consent
- •Elective PCI
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Contraindication to clopidogrel, aspirin or prasugrel
- •Weight <60kg
- •Previous stroke / TIA
- •Breast-feeding women
研究者
相似试验
进行中（未招募）
1 期
Assessment of platelet inhibitory response to clopidogrel when coadministered with a proton pump inhibitor - Plavix and PPI studyEUCTR2009-011543-40-GBPapworth Hospital72
已完成
4 期
Inhibition of platelet activation by clopidogrel in type II diabetes mellitus patientsdiabetes mellitus / diabetes1003553410012653NL-OMON32343niversitair Medisch Centrum Utrecht24
已完成
不适用
High-on Clopidogrel Platelet Reactivity as Assessed by Thromboelastography in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.I21I25I26Chronic ischaemic heart diseaseAcute myocardial infarctionPulmonary embolismDRKS00024509Kardiologie und Angiologie172
已完成
不适用
Platelet response to prasugrel and clopidogrel loadinig doses in elective PCI patientsElective PCIJPRN-UMIN000017624Division of Cardiovascular Medicine, Jichi Medical University School of Medicine40
已完成
不适用
Platelet Reactivity After Switching from Clopidogrel to Prasugrel in Chronic hemodialysis Patients with Coronary Artery DiseaseJPRN-UMIN000022139Chiba University Hospital41